A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)

NCT03192969 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Giant Cell Arteritis

Interventions

DRUG: Abatacept
OTHER: Placebo
DRUG: Glucocorticoid Treatment

Sponsor

Bristol-Myers Squibb